Skip to content

Multicenter prospective cohort study of mantle cell lymphoma

Multicenter prospective cohort study of mantle cell lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004161
Enrollment
150
Registered
2019-07-24
Start date
2019-05-24
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. A case of mantle cell lymphoma newly diagnosed by a pathologist (based on the classification criteria of WHO revised in 2016) 1) mantle cell lymphoma 2) leukemic nonnodal mantle cell lymphoma 3) in situ mantle cell neoplasia 2. 19 years or older 3. Patients signed informed consent form

Exclusion criteria

Exclusion criteria: 1. Lymphoma subtypes except the Inclusion criteria (based on the classification criteria of WHO revised in 2016) 2. Patients who do not understand or agree to the written Informed consent form 3. Patients who have a malignancy

Design outcomes

Primary

MeasureTime frame
Overall Survival

Secondary

MeasureTime frame
Primary treatment overall response rate;Salvage treatment overall response rate;Progression free survival

Countries

Korea, Republic of

Contacts

Public ContactYeong Jin KIM

Asan Medical Center

yjrla1410@gmail.com+82-2-3010-7816

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026